Toronto Stocks Inch Lower; AtkinsRealis Rises on 3Q Beat
By Adriano Marchese
Canadian stocks slightly lower in midday Friday trading. The S&P/TSX Composite Index is on track for a roughly 1% decline after the previous week's 5.8% rally. Sector performance was mixed in the session, with gains primarily in tech, energy and industrial services, offset by declines in consumer discretionary, health tech and materials.
Canada's S&P/TSX Composite Index were down 0.02% at 19582.76. The blue-chip S&P/TSX 60 fell by 0,08% to 1179.64.
Shares of AtkinsRealis, the name SNC-Lavalin Group is adopting, rose 4.4% to 42.21 Canadian dollars ($30.57) after the company reported higher third-quarter profit boosted by a disposal and better-than-expected revenue.
Other market movers:
Aurora Cannabis shares were 4.9% higher at C$0.64 after the Canadian cannabis company said stronger medical cannabis sales supported better-than-expected revenue and adjusted earnings growth in its second fiscal quarter.
Saputo's shares fell back by 6.9% to C$27.04 after the dairy company issued a cautious outlook following weaker sales in the recent quarter.
Stantec's shares rose by 7.5% to C$93.70 after the engineering company lifted its guidance for the year following stronger-than-expected earnings for the third quarter on continued strong demand, particularly in the U.S. and Canada.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
November 10, 2023 12:20 ET (17:20 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Berkshire Hathaway Earnings: Strong Insurance Results Continue to Lift Revenue and Profitability
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom